 | Issue navigator |
|
|
Contents of Volume 9 Suppl 1
Basic science, rationale, background and future of denosumab: a RANK ligand inhibitor
Reviews
Edited by Edward M Schwarz and Christopher T Ritchlin
Supported by an unrestricted grant from Amgen Inc.
|
Review
 
Biology of RANK, RANKL, and osteoprotegerin
Brendan F Boyce, Lianping Xing
Arthritis Research & Therapy 2007, 9(Suppl 1):S1 (29 June 2007)
[Full text] [PDF] [PubMed] [Related articles]
Review
Erosive arthritis
Georg Schett
Arthritis Research & Therapy 2007, 9(Suppl 1):S2 (29 June 2007)
[Full text] [PDF] [PubMed] [Related articles]
Review
Role of RANKL inhibition in osteoporosis
Michael McClung
Arthritis Research & Therapy 2007, 9(Suppl 1):S3 (29 June 2007)
[Full text] [PDF] [PubMed] [Related articles]
Review
Multiple myeloma/hypercalcemia
Babatunde O Oyajobi
Arthritis Research & Therapy 2007, 9(Suppl 1):S4 (29 June 2007)
[Full text] [PDF] [PubMed] [Related articles]
Review
Tumor metastasis to bone
Mandeep S Virk, Jay R Lieberman
Arthritis Research & Therapy 2007, 9(Suppl 1):S5 (29 June 2007)
[Full text] [PDF] [PubMed] [Related articles]
Review
Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies
Yousef Abu-Amer, Isra Darwech, John C Clohisy
Arthritis Research & Therapy 2007, 9(Suppl 1):S6 (29 June 2007)
[Full text] [PDF] [PubMed] [Related articles]
Review
Clinical development of anti-RANKL therapy
Edward M Schwarz, Christopher T Ritchlin
Arthritis Research & Therapy 2007, 9(Suppl 1):S7 (29 June 2007)
[Full text] [PDF] [PubMed] [Related articles]
| |
|  |
